I recently attended the Annual Life Sciences Panorama: Looking Ahead 2014 held at Genzyme in Cambridge, MA. Continue reading
From June 14 to July 13, 2011 there will be a series of seminars Preventing Errors and Out-of-Specifications Results in Pharma and Biotech via Newer Approaches/Technologies across North America. Continue reading
On July 1, Dr. Stephen Rowe of Chilworth Technology will present Safe Scale-up of Chemical Processes: Holistic Strategies Supported by Modern Tools.
This online process safety seminar will focus on the overall safety strategy and outlines:
In 1969, the USA Congressional Joint Committee on Atomic Energy held a hearing at the head of the Fermi National Accelerator Laboratory and was being questioned on why build a new $250 million particle collider. What did a particle collider have to do with the security of the country? Physicist Robert Wilson replied “It has nothing to do directly with defending our country except to make it worth defending.” 1
Over the last five years, FDA and ICH quality initiatives created a paradigm shift in pharmaceutical discovery, development, and manufacturing. At the 17th International Process Development Conference, Christine Moore gave a presentation on the FDA perspective on Quality by Design (QbD) in pharmaceutical development. During her presentation, Christine discussed the advantages that the U.S. Food and Drug Administration (FDA) believes Quality by Design offers, including: Continue reading
At the 2009 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting in Los Angeles, Gerald Burke presented a case study on how Patheon Pharmaceuticals improved roller compaction processes. Specifically, the case study focused on the influence of roller compactor settings on Critical Quality Attributes (CQAs) and the early prediction and control of granule porosity. Continue reading
Last month, I attended the 11th International Petrophase Conference in New Jersey, USA. Topics discussed at the 11th International Petrophase Conference included petroleum phase behavior, the formation and mitigation of organic solid phases, emulsions and colloids, desalting, and the structure and composition of heavy oils, asphaltenes, and trace contaminants. After speaking with several other delegates, I was reminded that there are few process analytical instruments that could measure droplets or particles within crude oil or at elevated pressure field installations. Continue reading